Booth 3G188

NXT USA and its partner Laila Nutra Private Ltd will co-exhibit at Vitafoods Europe 2026, showcasing a portfolio of science-backed ingredients shown in clinical studies to deliver measurable, real-world outcomes.

“We’re excited to be in Barcelona with Laila Nutra and connect with forward-thinking Brands from around the world,” said Eric Anderson, managing director of NXT USA. “The industry is moving past fad ingredients and hyperbolic claims and toward demonstrated performance. Brands want ingredients that not only stand out but also stand up to scrutiny. That’s exactly where we focus.”

The highlights will include:

• Xeya Modern Shatavari, a high-potency, low-dose shatavari standardized for women’s hormonal health across life stages. The ingredient is shown to support hormone balance, reproductive health, and menopausal symptom relief.
• BluNADBooster, an NAD+ ingredient shown in a clinical study last year to increase endogenous NAD+ levels and preserve them by targeting CD38 activity. Clinical studies show the ingredient supports cognitive performance, energy, and endurance.
• Digexin, a digestive health solution shown to support digestive regularity and comfort in as little as 7 days, in a general population as well as in people using GLP-1 medications.
• TamaFlex, a joint health ingredient shown to deliver benefits within 5 days. Human studies demonstrate that it supports both rapid relief and long-term joint structure benefits.

NXT USA’s ingredients are each supported by patient-reported outcomes, physician assessments, biomarker analysis, and physical measurements, the company reported. Together with Laila Nutra, NXT USA will demonstrate how global partnerships can accelerate innovation and bring clinically meaningful solutions to market faster.

“Great ingredients don’t just come from great science, they come from great collaboration,” said Anderson. “Our partnership with Laila Nutra is about scaling impact: bringing proven solutions to more brands, in more markets, faster.”